501 filings
Page 6 of 26
8-K
6yyfxry47cahhxiz04e
3 May 18
Submission of Matters to a Vote of Security Holders
8:30am
8-K
rz0 wgyy5axc
30 Apr 18
Allergan Reports 3% Increase in First Quarter 2018 GAAP Net Revenues to $3.7 Billion
7:15am
DEFA14A
1r62a3
16 Apr 18
Additional proxy soliciting materials
12:00am
DEFA14A
0do6lv7l4g4wh58pkx
9 Apr 18
Additional proxy soliciting materials
12:00am
DEFA14A
to9c4utwt23icml1ff3
6 Apr 18
Additional proxy soliciting materials
12:00am
DEFA14A
l81kvm79nk0 ej
23 Mar 18
Additional proxy soliciting materials
12:00am
25-NSE
ez7itro63qe0qxw91f
1 Mar 18
Exchange delisting
12:00am
S-3ASR
ln6zf9wd5r9lie80
16 Feb 18
Automatic shelf registration
12:00am
8-K
x82yjnxy
9 Feb 18
Other Events
12:00am
8-K
no4cxe735
6 Feb 18
Allergan Reports Solid Finish to 2017 with 12% Increase in Fourth Quarter GAAP Net Revenues to $4.3 Billion
12:00am
8-K
kiwppxwlseadtrpu
5 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
6jtkug2
1 Feb 18
Results of Operations and Financial Condition
12:00am
SC TO-T/A
at4nn1dyrwjil
30 Jan 18
Third party tender offer statement (amended)
12:00am
8-K
z7z ymge0fwa
8 Jan 18
Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference
12:00am
SC TO-T/A
61y6rt468febg gnct3
5 Jan 18
Third party tender offer statement (amended)
12:00am
SC TO-T/A
b841g
4 Jan 18
Third party tender offer statement (amended)
12:00am